Cargando…

Erythroleukemia: Classification

Acute erythroid leukemia (AEL) is a rare (2%–5%) form of acute myeloid leukemia (AML). Molecular alterations found in AEL resemble those of other AMLs. We report a classification of AELs in three major classes, with different prognosis and some specific features such as a tendency to mutual exclusio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cervera, Nathalie, Guille, Arnaud, Adélaïde, José, Hospital, Marie‐Anne, Garciaz, Sylvain, Mozziconacci, Marie‐Joelle, Vey, Norbert, Gelsi‐Boyer, Véronique, Birnbaum, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Short Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188454/ https://www.ncbi.nlm.nih.gov/pubmed/37206278 http://dx.doi.org/10.1002/jha2.676

Ejemplares similares

Revisiting gene mutations and prognosis of ex-M6a-acute erythroid leukemia with regard to the new WHO classification
por: Cervera, N, et al.
Publicado: (2017)

Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients
por: Garciaz, Sylvain, et al.
Publicado: (2022)

Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases
por: Gelsi-Boyer, Véronique, et al.
Publicado: (2012)

Myeloid malignancies: mutations, models and management
por: Murati, Anne, et al.
Publicado: (2012)

Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes
por: Devillier, Raynier, et al.
Publicado: (2015)

Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias
por: Rocquain, Julien, et al.
Publicado: (2010)

Rare mutations in DNMT3A in myeloproliferative neoplasms and myelodysplastic syndromes
por: Brecqueville, M, et al.
Publicado: (2011)

Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes
por: Gelsi-Boyer, Véronique, et al.
Publicado: (2008)

Venetoclax in Acute Myeloid Leukemia: Molecular Basis, Evidences for Preclinical and Clinical Efficacy and Strategies to Target Resistance
por: Garciaz, Sylvain, et al.
Publicado: (2021)

Mutations and deletions of the SUZ12 polycomb gene in myeloproliferative neoplasms
por: Brecqueville, M, et al.
Publicado: (2011)

FMS-Like Tyrosine Kinase 3 Inhibitors in the Treatment of Acute Myeloid Leukemia: An Update on the Emerging Evidence and Safety Profile
por: Garciaz, Sylvain, et al.
Publicado: (2023)

Multiple cytogenetics forms of KMT2A amplification and jumping translocation in a case of myelodysplastic syndrome
por: Ittel, Antoine, et al.
Publicado: (2021)

Targeting regulated cell death pathways in acute myeloid leukemia
por: Garciaz, Sylvain, et al.
Publicado: (2023)

Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia
por: Collette, Y, et al.
Publicado: (2015)

Activation of the intrinsic and extrinsic pathways in high pressure-induced apoptosis of murine erythroleukemia cells
por: Yamaguchi, Takeo, et al.
Publicado: (2007)

A chemogenomic approach to identify personalized therapy for patients with relapse or refractory acute myeloid leukemia: results of a prospective feasibility study
por: Collignon, A., et al.
Publicado: (2020)

Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers
por: Letessier, Anne, et al.
Publicado: (2006)

Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization
por: Sabatier, Renaud, et al.
Publicado: (2014)

PB1844: REAL: A RETROSPECTIVE STUDY OF THE CLINICO-BIOLOGICAL FEATURES OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES PATIENTS INCLUDED IN AN EARLY PHASE TRIAL AT A COMPREHENSIVE CANCER CENTER.
por: Berton, Guillaume, et al.
Publicado: (2023)

Molecular Landscapes and Models of Acute Erythroleukemia
por: Fagnan, Alexandre, et al.
Publicado: (2021)

P548: PRELIMINARY RESULTS OF A PHASE 1, FIRST-IN-HUMAN STUDY OF INA03, AN ANTI-CD71 ANTIBODY-DRUG CONJUGATE IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE LEUKEMIAS
por: Garciaz, Sylvain, et al.
Publicado: (2023)

Signaling pathway switch in breast cancer
por: Guille, Arnaud, et al.
Publicado: (2013)

Erythroleukemia cells acquire an alternative mitophagy capability
por: Wang, Jian, et al.
Publicado: (2016)

Down-Regulation of ECRG4, a Candidate Tumor Suppressor Gene, in Human Breast Cancer
por: Sabatier, Renaud, et al.
Publicado: (2011)

Hypomethylation of DNA during differentiation of friend erythroleukemia cells
por: Christman, JK, et al.
Publicado: (1980)

c-myc protooncogene expression in mouse erythroleukemia cells.
por: Lachman, H M
Publicado: (1989)

Erythroleukemia Relapsing as Precursor B-cell Lymphoblastic Leukemia
por: Park, Borae G., et al.
Publicado: (2011)

Chronic lymphocytic leukemia followed by myelodysplastic syndrome and erythroleukemia
por: Cazaceanu, O, et al.
Publicado: (2012)

Expression analysis of LIM gene family in poplar, toward an updated phylogenetic classification
por: Arnaud, Dominique, et al.
Publicado: (2012)

Synthesis of globin RNA in enucleated differentiating murine erythroleukemia cells
Publicado: (1987)

Cholesterol esterification during differentiation of mouse erythroleukemia (Friend) cells
por: Mulas, Maria Franca, et al.
Publicado: (2011)

Erythroleukemia treated effects of rat plasma profile and erythrocyte membranes
por: Yu, Liqun, et al.
Publicado: (2020)

Functional Evaluation of KEL as an Oncogenic Gene in the Progression of Acute Erythroleukemia
por: Liu, Wenjie, et al.
Publicado: (2022)

Multicolour-banding fluorescence in situ hybridisation (mbanding-FISH) to identify recurrent chromosomal alterations in breast tumour cell lines
por: Letessier, A, et al.
Publicado: (2005)

ZNF703 mRNA-Targeting Antisense Oligonucleotide Blocks Cell Proliferation and Induces Apoptosis in Breast Cancer Cell Lines
por: Udu-Ituma, Sandra, et al.
Publicado: (2023)

Multi-stage Friend murine erythroleukemia: molecular insights into oncogenic cooperation
por: Moreau-Gachelin, Françoise
Publicado: (2008)

Biosynthesis of spectrin and its assembly into the cytoskeletal system of Friend erythroleukemia cells
Publicado: (1986)

A fibronectin matrix is required for differentiation of murine erythroleukemia cells into reticulocytes
Publicado: (1987)

Developmental program of murine erythroleukemia cells. Effect of the inhibition of protein synthesis
Publicado: (1979)

Calcium regulates the commitment of murine erythroleukemia cells to terminal erythroid differentiation
Publicado: (1981)

Cannot write session to /tmp/vufind_sessions/sess_171t5b4l4n3pps0m4bu603h163